Posted on Sep. 17th, 2012 at 11:45am
Enfamil Human Milk Fortifier Acidified Liquid is another example of Mead Johnson’s commitment to pediatric nutrition, including our support of breastfeeding mothers.
A study published in the esteemed journal Pediatrics describes the benefits and safety of Enfamil® Human Milk Fortifier Acidified Liquid over powdered fortifiers. The study demonstrated that premature infants given this new Mead Johnson product achieved significantly higher growth than infants given powdered fortifiers, and that Mead Johnson’s ultra-concentrated liquid fortifier is well tolerated by premature infants.
A team of talented Mead Johnson scientists has created the first and only ultra-concentrated liquid human milk fortifier marketed in the United States that offers nearly 20 percent more protein than current powdered fortifiers. Further, it is the only product that meets all safety and preparation guidelines from the Academy of Nutrition and Diabetics and the Centers for Disease Control and Prevention, as well as new preterm nutrition guidelines from the European Society for Pediatric Gastroenterology, Hepatology and Nutrition.
The study authors were comprised of talented Mead Johnson scientists — Kelly R. Walsh, PhD, RD: Department of Nutrition Science, Research and Development, and Carol Lynn Berseth, MD: Clinical Research, Department of Medical Affairs – and two leading neonatal experts: Fernando Moya, MD: Coastal Carolina Neonatology, and Paula M. Sisk, PhD: Department of Pediatrics, Wake Forest University School of Medicine.
According to Dr. Berseth, “We designed this ultra-concentrated fortifier to meet the nutritional needs of rapidly growing premature infants, while minimizing the dilution of the mother’s breast milk which provides important health benefits.”
“Nowhere is our company’s commitment to its mission of nourishing the world’s babies and children for the best start in life more evident than when we are engaging in cutting-edge nutritional research,” commented Dirk Hondmann, Mead Johnson’s head of Global Research and Development. “Those focused efforts enable the creation of breakthrough products such as this fortifier, to benefit the most fragile and vulnerable of infants.”
To access the full article in Pediatrics, please click here.